The clinical significance of this combination of findings, including the potential for compound heterozygosity in ABCA4 (given the potentially pathogenic nature of the identified variant and the recessive inheritance of Stargardt disease), and the impact of the GBA1 variant in conjunction with the CNV, requires further investigation and correlation with the proband’s phenotype and family history. This evidence concerns the gene GBA1 and Stargardt disease.